| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |